Alternative Energy Partners Inc (AEGY)

[DeDe3]

An Official US Govt. Position on Utilizing Cannabinoid Medicine in the Treatment of Various Cancers.Berkeley Bio-Organic Research Laboratories
October 11, 2013

Please 'like' BerkeleyBio's page

https://www.facebook.com/berkeleybio

This is taken directly from the National Cancer Institute's PDQ file, which is designed to inform doctors of various advances and new uses of medicines and medicinal techniques. It is written by Don Abrams, who recently closely observed the successful treatment of 25 advanced cancer patients with "unofficial" Simpson oil, as indicated in another link elsewhere on this site.

Dr. Abrams has applied for some "official" oil from the government marijuana farm in Mississippi. The guy who runs the farm has it sitting there for him. But the government won't let it happen. Even after all the recent scientific studies that have resulted in Dr. Abrams giving the following advice to Doctors, as an official voice of the US Govt., they are stifling the research as they always have.

Here is the entire section on treating cancer with cannabinoids. This what the government wants Doctors to know when patients ask about cannabis medicine. It is a huge change from last year's version.

"Antitumor Effects

One study in mice and rats suggested that cannabinoids may have a protective effect against the development of certain types of tumors.[3] During this 2-year study, groups of mice and rats were given various doses of THC by gavage. A dose-related decrease in the incidence of hepatic adenoma tumors and hepatocellular carcinoma (HCC) was observed in the mice. Decreased incidences of benign tumors (polyps and adenomas) in other organs (mammary gland, uterus, pituitary, testis, and pancreas) were also noted in the rats. In another study, delta-9-THC, delta-8-THC, and cannabinol were found to inhibit the growth of Lewis lung adenocarcinoma cells in vitro and in vivo .[4] In addition, other tumors have been shown to be sensitive to cannabinoid-induced growth inhibition.[5-8]

Cannabinoids may cause antitumor effects by various mechanisms, including induction of cell death, inhibition of cell growth, and inhibition of tumor angiogenesis invasion and metastasis.[9-12] One review summarizes the molecular mechanisms of action of cannabinoids as antitumor agents.[13] Cannabinoids appear to kill tumor cells but do not affect their nontransformed counterparts and may even protect them from cell death. These compounds have been shown to induce apoptosis in glioma cells in culture and induce regression of glioma tumors in mice and rats. Cannabinoids protect normal glial cells of astroglial and oligodendroglial lineages from apoptosis mediated by the CB1 receptor.[14]

The effects of delta-9-THC and a synthetic agonist of the CB2 receptor were investigated in HCC.[15] Both agents reduced the viability of HCC cells in vitro and demonstrated antitumor effects in HCC subcutaneous xenografts in nude mice. The investigations documented that the anti-HCC effects are mediated by way of the CB2 receptor. Similar to findings in glioma cells, the cannabinoids were shown to trigger cell death through stimulation of an endoplasmic reticulum stress pathway that activates autophagy and promotes apoptosis. Other investigations have confirmed that CB1 and CB2 receptors may be potential targets in non-small cell lung carcinoma [16] and breast cancer.[17]

An in vitro study of the effect of CBD on programmed cell death in breast cancer cell lines found that CBD induced programmed cell death, independent of the CB1, CB2, or vanilloid receptors. CBD inhibited the survival of both estrogen receptor–positive and estrogen receptor–negative breast cancer cell lines, inducing apoptosis in a concentration-dependent manner while having little effect on nontumorigenic, mammary cells.[18]

CBD has also been demonstrated to exert a chemopreventive effect in a mouse model of colon cancer.[19] In the experimental system, azoxymethane increased premalignant and malignant lesions in the mouse colon. Animals treated with azoxymethane and CBD concurrently were protected from developing premalignant and malignant lesions. In in vitro experiments involving colorectal cancer cell lines, the investigators found that CBD protected DNA from oxidative damage, increased endocannabinoid levels, and reduced cell proliferation.

Another investigation into the antitumor effects of CBD examined the role of intercellular adhesion molecule-1 (ICAM-1).[12] ICAM-1 expression has been reported to be negatively correlated with cancer metastasis. In lung cancer cell lines, CBD upregulated ICAM-1, leading to decreased cancer cell invasiveness.

In an in vivo model using severe combined immunodeficient mice, subcutaneous tumors were generated by inoculating the animals with cells from human non-small cell lung carcinoma cell lines.[20] Tumor growth was inhibited by 60% in THC-treated mice compared with vehicle-treated control mice. Tumor specimens revealed that THC had antiangiogenic and antiproliferative effects. However, research with immunocompetent murine tumor models has demonstrated immunosuppression and enhanced tumor growth in mice treated with THC.[21,22]

In addition, both plant-derived and endogenous cannabinoids have been studied for anti-inflammatory effects. A mouse study demonstrated that endogenous cannabinoid system signaling is likely to provide intrinsic protection against colonic inflammation.[23] As a result, a hypothesis that phytocannabinoids and endocannabinoids may be useful in the risk reduction and treatment of colorectal cancer has been developed.[24-27]

CBD may also enhance uptake of cytotoxic drugs into malignant cells. Activation of the transient receptor potential vanilloid type 2 (TRPV2) has been shown to inhibit proliferation of human glioblastoma multiforme cells and overcome resistance to the chemotherapy agent carmustine.[28] In an in vitro model, CBD increased TRPV2 activation and increased uptake of cytotoxic drugs, leading to apoptosis of glioma cells without affecting normal human astrocytes. This suggests that coadministration of CBD with cytotoxic agents may increase drug uptake and potentiate cell death in human glioma cells."

I find it very interesting that there is such a myriad of proven mechanisms that Dr. Abrams refers to, and not a single negative. As this is coming from the government, one would think that they would try very hard to find some sort of detraction from this amazingly rosy picture of potential help in fighting cancer. The reason no negatives are listed here is very simple: There are none.

Dave

Note: Every study that Dr. Abrams used to come to these conclusions are footnoted and can be referenced on the National Cancer Institute site.

There is a link on the bottom of this page to access the NCI site. I wrote about it months ago here and this piece is somewhat of a rehash of that. I just find it amazing that they won't even give the oil to the guy who wrote the official government advice to doctors on the subject, and is one of the few that has carried out other official government-sponsored research with cannabis in the past.

Could it perhaps be that his last double-blind placebo-controlled cannabis study showed that a person in pain who uses Vicodin regularly can get equal pain relief on half the dose, if the patients inhales some burning marijuana flowers several times a day?

thanks Green Up!!